P&U's Nicotrol Inhaler Launched In USA

18 May 1997

Pharmacia & Upjohn's new nicotine product, Nicotrol Inhaler, has beenapproved and launched in the USA, to help smokers quit the habit. The company says it is the first product to provide smokers with a hand-to-mouth administration, which may satisfy some of the "ritual" elements of smoking, as well as supplying nicotine to alleviate craving.

Pivotal trials have shown that compared to a placebo, Nicotrol Inhaler doubled the likelihood that a smoker would remain abstinent for a year.

The product will be available on prescription in the USA. It is already sold over-the-counter in Denmark, Sweden and Italy, and has OTC applications pending in five other countries, including the UK. Prescription sale is approved in the Netherlands, while applications are pending in five other countries. P&U also markets patch and nasal spray formulations.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight